Key Findings:  The data support the interest of the CB2 receptor as a potential pharmacological target in LRRK2 transgenic mice, although the neuronal substrates underlying these benefits might be not completely related to the basal ganglia and to the presumed parkinsonian features of these mice.
Type of Study:  Animal Study
Study Result:  Positive
Cannabinoids Studied:  Not Applicable
Phytocannabinoid Source:  Not Applicable